Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study

  • García-Gutiérrez, María Salud
  • Torregrosa, Abraham B.
  • Navarrete, Francisco
  • Aracil-Fernández, Auxiliadora
  • Rubio, Gabriel
  • Manzanares, Jorge
[Aims] To describe differences in the expression of genes encoding cannabinoid receptors (CNR1, CNR2), the associated receptor GRP55 and the enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGLL) between individuals with alcohol use disorder (AUD) and controls in key mesocorticolimbic brain regions., [Design] Case-control, observational postmortem study comparing gene expression in brain tissue from individuals diagnosed with AUD and matched controls. The study was not pre-registered and should therefore be considered exploratory., [Setting] Brain collection from the New South Wales Tissue Resource Centre (NSWTRC) at the University of Sydney, Australia., [Participants/cases] Brain samples were obtained from 18 patients with AUD (mean alcohol use = 35.5 ± 8.7 drinking years) and 18 controls (C). Groups were matched for age (AUD: 55.8 ± 9; C: 56.3 ± 9.4) and postmortem interval (AUD: 39.7 ± 16.9 h; C: 31.8 ± 13.2 h)., [Measurements] Relative gene expression of CNR1, CNR2, GPR55, FAAH and MGLL was quantified using real-time polymerase chain reaction (qPCR) in the prefrontal cortex (PFC) and nucleus accumbens (NAc)., [Findings] Compared with controls, individuals with AUD showed higher CNR1 in the PFC (+125%) and NAc (+78%) and lower CNR2 expression in both regions (PFC: −50%; NAc: −49%). GPR55 was higher in the PFC (+19%) and lower in the NAc (−51%). FAAH expression was lower in the PFC (−15%) and higher in the NAc (+24%), whereas MGLL expression did not differ in the PFC and was lower in the NAc (−15%)., [Conclusions] This descriptive postmortem study identifying region-specific differences in endocannabinoid system gene expression between individuals with alcohol use disorder (AUD) and controls supports an involvement of the endocannabinoid system in the neuropathological features associated with AUD, although causal relationships cannot be inferred., Tissues were received from the New South Wales Brain Tissue Resource Centre at the University of Sydney, which the University of Sydney supports. Research reported in this publication was supported by the National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health under award number R28AA012725. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. We thank the Bioinformatics Service of the Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain, for providing statistical support., This research was supported by grants from the Ministry of Health, Spain (PNSD 2011/043), ‘Red Temática de Investigación Cooperativa en Salud’ (RETICS, Instituto de Salud Carlos III, MICINN and FEDER, Madrid, Spain, ‘Red Nacional de Trastornos Adictivos’, RD06/0001/1004) and Red de Investigación en Atención Primaria de Adicciones, Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, grant number RD21/0009/0008 and RD24/0003/0002 to J.M. and Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). The Instituto de Neurociencias is a ‘Centre of Excellence Severo Ochoa’ (CEX2021-001165-S). A.B.T. is a predoctoral fellow supported by Red de Investigación en Atención Primaria de Adicciones (Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, grant number RD21/0009/0008 and RD24/0003/0002)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed